Based on promotion effects of upregulation of COL4A1 in tumor growth through activating FAK-Src signaling in HCC cells, we wonder if FAK or Src inhibitor could effectively suppress the growth of HCC cells with high expression of COL4A1. Here, SRC is linked to hepatocellular carcinoma.